Apelin-13 protects dopaminergic neurons in MPTP-induced Parkinson's disease model mice through inhibiting endoplasmic reticulum stress and promoting …
J Zhu, S Dou, Y Jiang, J Chen, C Wang, B Cheng - Brain Research, 2019 - Elsevier
The dopaminergic neurodegeneration in the substantia nigra pars compacta (SNpc) and
striatum of the midbrain is the important pathological feature of Parkinson's disease (PD). It …
striatum of the midbrain is the important pathological feature of Parkinson's disease (PD). It …
Apelin-36 mediates neuroprotective effects by regulating oxidative stress, autophagy and apoptosis in MPTP-induced Parkinson's disease model mice
J Zhu, W Gao, X Shan, C Wang, H Wang, Z Shao… - Brain research, 2020 - Elsevier
Abstract Parkinson's disease (PD), a common human neurodegenerative disorder, is
characterized by the presence of intraneuronal Lewy bodies composed principally of …
characterized by the presence of intraneuronal Lewy bodies composed principally of …
Apelin-13 protects dopaminergic neurons against rotenone—Induced neurotoxicity through the AMPK/mTOR/ULK-1 mediated autophagy activation
P Chen, Y Wang, L Chen, N Song, J Xie - International Journal of …, 2020 - mdpi.com
Parkinson's disease (PD) is characterized by the progressive loss of dopaminergic neurons
in the substantia nigra pars compacta. Several brain–gut peptides are able to exert …
in the substantia nigra pars compacta. Several brain–gut peptides are able to exert …
Apelin-36 mitigates MPTP/MPP+-induced neurotoxicity: Involvement of α-synuclein and endoplasmic reticulum stress
J Zhu, S Dou, C Wang, Y Jiang, C Wang, B Cheng - Brain Research, 2019 - Elsevier
Parkinson's disease (PD) is characterized by the progressive loss of dopaminergic neurons
within the substantia nigra compacta (SNpc) which leads to the behavioral dysfunction. In …
within the substantia nigra compacta (SNpc) which leads to the behavioral dysfunction. In …
Apelin-36 exerts the cytoprotective effect against MPP+-induced cytotoxicity in SH-SY5Y cells through PI3K/Akt/mTOR autophagy pathway
J Zhu, S Dou, Y Jiang, B Bai, J Chen, C Wang… - Life sciences, 2019 - Elsevier
Aims Parkinson's disease (PD) is a common neurodegenerative disease typically
associated with the accumulation of α-synuclein. Autophagy impairment is thought to be …
associated with the accumulation of α-synuclein. Autophagy impairment is thought to be …
Apelin-13 ameliorates cognitive impairments in 6-hydroxydopamine-induced substantia nigra lesion in rats
Although Parkinson's disease (PD) is well known with its motor deficits, the patients often
suffer from cognitive dysfunction. Apelin, as the endogenous ligand of the APJ receptor, is …
suffer from cognitive dysfunction. Apelin, as the endogenous ligand of the APJ receptor, is …
Apelin-13 protects PC12 cells against methamphetamine-induced oxidative stress, autophagy and apoptosis
Methamphetamine (METH) is a potent psychomotor stimulant that has a high potential for
abuse in humans. In addition, it is neurotoxic, especially in dopaminergic neurons. Long …
abuse in humans. In addition, it is neurotoxic, especially in dopaminergic neurons. Long …
Apelin-13 prevents hippocampal synaptic plasticity impairment in Parkinsonism rats
The hippocampus is involved in learning and memory for novel information and implicated
within the cognitive dysfunction in Parkinson's disease. Long-term potentiation (LTP), the …
within the cognitive dysfunction in Parkinson's disease. Long-term potentiation (LTP), the …
Protective role of Apelin-13 on amyloid β25–35-induced memory deficit; Involvement of autophagy and apoptosis process
S Aminyavari, M Zahmatkesh, M Farahmandfar… - Progress in Neuro …, 2019 - Elsevier
Alzheimer's disease (AD) by progressive neurodegenerative pattern is associated with
autophagy stress which is suggested as a potential cause of amyloid β (Aβ) aggregation and …
autophagy stress which is suggested as a potential cause of amyloid β (Aβ) aggregation and …
Protective effect of neuropeptide apelin-13 on 6-hydroxydopamine-induced neurotoxicity in SH-SY5Y dopaminergic cells: involvement of its antioxidant and …
E Pouresmaeili-Babaki, S Esmaeili-Mahani… - Rejuvenation …, 2018 - liebertpub.com
Parkinson's disease (PD) is a severe neurodegenerative disorder characterized by the loss
of brain dopaminergic neurons. Beside pharmacologic and symptomatic treatment of PD the …
of brain dopaminergic neurons. Beside pharmacologic and symptomatic treatment of PD the …